Baird Financial Group
PAHC icon

Baird Financial Group’s Phibro Animal Health PAHC Stock Holding History

Baird Financial Group’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$336K Buy
10,710
+279
+3% +$11.8K ﹤0.01% 1689
2026
Q1 		$577K Buy
10,431
+1,485
+17% +$70.7K ﹤0.01% 1430
2025
Q4 		$334K Buy
+8,946
New +$363K ﹤0.01% 1604
2019
Q4 		– Sell
-138,421
Closed -$2.95M – 1540
2019
Q3 		$2.95M Buy
138,421
+22,650
+20% +$620K 0.01% 662
2019
Q2 		$3.68M Buy
115,771
+91,115
+370% +$2.86M 0.01% 606
2019
Q1 		$814K Buy
+24,656
New +$767K ﹤0.01% 919

Other funds holding PAHC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Baird Financial Group's PAHC Position: Q2 2026 in Review

Baird Financial Group increased its Phibro Animal Health (PAHC) stake by 2.7% in Q2 2026, buying an estimated $11.8K and bringing the position to 10,710 shares worth $336K. The position accounts for ﹤0.01% of the portfolio, ranked #1689.

Baird Financial Group first reported a position in PAHC in Q1 2019 and has held it in 6 quarters since. The position peaked at $3.68M in Q2 2019. 209 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.

  • Baird Financial Group held 10,710 shares of Phibro Animal Health worth $336K as of Q2 2026.
  • Baird Financial Group bought 279 Phibro Animal Health shares in Q2 2026, an estimated $11.8K.
  • Phibro Animal Health made up ﹤0.01% of Baird Financial Group's portfolio in Q2 2026, its #1689 holding.
  • Baird Financial Group first reported a position in Phibro Animal Health in Q1 2019 and has held it in 6 quarters since.
  • Baird Financial Group's Phibro Animal Health position peaked at $3.68M in Q2 2019.
  • 209 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.

Based on Baird Financial Group's 13F filing for Q2 2026, filed 12 Aug 2026.